Physiogel

The whole proposition rests on a piece of engineering with a deliberately unglamorous name: Derma Membrane Structure, or DMS. Rather than the classic oil-in-water emulsion that most lotions use, these formulas are built from plant-derived lipids arranged to mimic the lamellar layering of the skin's own barrier, including ceramides and physiological lipids structured to slot into a depleted barrier and help it hold water for days rather than hours. That biomimetic galenics, not a celebrity active, is the technical heart of the line, and it explains why the products skip fragrance, preservatives, and emulsifiers that reactive skin tends to flag. The commercial story behind the brand is a study in corporate hand-offs. Its dermatological pharmaceutical lineage runs back to the nineteenth century, but the modern beauty arc turned in 2009, when GlaxoSmithKline absorbed that dermatology business for roughly 2.9 billion dollars, folding the barrier-repair line into a global consumer-health portfolio. A decade later the rights fractured along geography, with the Asia and North America territories changing hands separately, which matters to shoppers because it means the exact formula and even the availability can differ depending on which market's version you buy. The DMS approach has since been updated and rebranded with newer biomimetic marketing language, though the underlying logic has stayed remarkably consistent: replace what a damaged barrier is missing using ingredients close to what the skin makes itself. The practical caveats are logistical rather than scientific. Cross-border supply is inconsistent, the packaging and naming shift by region, and beneath the technical vocabulary this remains, at its core, an exceptionally well-built lipid-and-ceramide barrier cream. For eczema-prone, reactive, or severely dry skin, that restraint is the entire point and the strongest endorsement.

Sources:[1][2][3]